• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MERIT MEDICAL, INC - ROISSY EMBOSPHERE®; AGENTS, EMBOLIC, FOR TREATMENT OF UTERINE FIBROIDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MERIT MEDICAL, INC - ROISSY EMBOSPHERE®; AGENTS, EMBOLIC, FOR TREATMENT OF UTERINE FIBROIDS Back to Search Results
Catalog Number S410GH/CNA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Abdominal Pain (1685)
Event Date 02/13/2023
Event Type  Injury  
Event Description
The account alleges post a bilateral uterine artery embolization procedure the patient experienced severe postoperative abdominal pain, which required oral non-steroidal anti-inflammatory drugs, pteridine intramural injection, and morphine subcutaneous injection for pain relief.After above treatment, abdominal pain was gradually relieved.No additional information available.
 
Manufacturer Narrative
The suspect device is not expected to return for evaluation.A follow up will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The suspect device was not returned for evaluation.The complaint could not be confirmed.The root cause could not be determined.A search of the complaint database was performed and no similar complaints for this lot number were found.The device history record was reviewed, and no exception documents were found.Abdominal pain is one of the most frequently anticipated post procedure complications listed in the product's instruction for use known as "post-embolization syndrome.This anticipated complication has already been identified in the product's risk management file and the current assessment still adequate.
 
Manufacturer Narrative
The suspect device is not expected to return for evaluation.The complaint could not be confirmed.The root cause could not be determined.A review of the device history and complaint database could not be performed since the lot number was not provided.Should the device be returned later, the investigation will be reopened.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOSPHERE®
Type of Device
AGENTS, EMBOLIC, FOR TREATMENT OF UTERINE FIBROIDS
Manufacturer (Section D)
MERIT MEDICAL, INC - ROISSY
bat. a- parc des nations
383 rue de la belle etoile
roissy charles de gaulle, cedex 95958
FR  95958
Manufacturer (Section G)
MERIT MEDICAL, INC - ROISSY
bat. a- parc des nations
383 rue de la belle etoile
roissy charles de gaulle, cedex 95958
FR   95958
Manufacturer Contact
bryson heaton
1600 merit parkway
south jordan, UT 84095
8012084662
MDR Report Key18466527
MDR Text Key332332191
Report Number9615728-2024-00001
Device Sequence Number1
Product Code NAJ
UDI-Device Identifier00884450403402
UDI-Public00884450403402
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
K021397
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 12/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberS410GH/CNA
Device Lot NumberX2588763_
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/19/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/02/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-